Express Pharma

Kiran Mazumdar-Shaw ranked No. 2 in Global ‘Medicine Maker Power List’ 2015

107

She is the only India based business leader featuring on the list

Kiran Mazumdar-Shaw, Chairperson and Managing Director, Biocon, has been ranked No. 2 on ‘The Medicine Maker Power List’ 2015, an index of the 100 most influential people across the globe in the field of medicine.

Mazumdar-Shaw appears on the list alongside global leaders from the industry, including CEOs, professors, Nobel Prize winning researchers and many other celebrated scientists from the pharmaceutical world.

The Top 5 on ‘The Medicine Maker Power List’ are Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases, USA, Kiran Mazumdar-Shaw, Chairperson and Managing Director, Biocon, Sir Andrew Witty, Chief Executive Officer, GlaxoSmithKline, Arthur D Levinson, Chief Executive Officer, Calico and Heather Bresch, Chief Executive Officer, Mylan.

The list also includes names like Pascal Soriot, Chief Executive Officer, AstraZeneca; Robert A. Bradway, Chairman and Chief Executive Officer, Amgen; Ian C Read, Chairman, Pfizer; Prof. Tyler Jacks, Koch Institute for Integrative Cancer Research; Prof.Charles Cooney, Massachusetts Institute of Technology, USA; Prof Harold Varmus, Weil Cornell Medical College and many more.

Mazumdar- Shaw is the only India based business leader featuring on the list. The Medicine Maker is a UK-based publication that is distributed worldwide to a targeted European and North American industry professionals. The power list has been compiled from reader nominations with the help of expert judges and is based entirely on merit.

It was developed in three stages. In stage one, The Medicine Maker invited readers to nominate those who they thought deserved recognition. In stage two, a jury of four noted medicine makers selected their top 100 from the slate of nominees: the results were consolidated into a list of 100 names. In the final stage, the jury ranked the list, and the average rankings were combined to provide the final power list.

- Advertisement -

Comments are closed.